Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy

被引：8

作者：

Annaberdyev, Shohrat ^{[1
]}

Gibbons, Joseph ^{[2
]}

Hardacre, Jeffrey M. ^{[1
,3
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA

[2] Univ Hosp Case Med Ctr, Div Hematol Oncol, Cleveland, OH USA

[3] Univ Hosp Case Med Ctr, Div Surg Oncol, Cleveland, OH USA

来源：

WORLD JOURNAL OF SURGICAL ONCOLOGY | 2009年 / 7卷

关键词：

SURGICAL RESECTION; MESYLATE;

D O I：

10.1186/1477-7819-7-30

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the alimentary tract and are believed to derive from the interstitial Cell of Cajal. Imatinib mesylate (Gleevec(R); Novartis, Basel, Switzerland) has revolutionized the treatment of GISTs and is generally used in the metastatic and adjuvant settings. We report the case of a 61-year old man who was treated with neoadjuvant imatinib for a massive gastric GIST with the hope of avoiding a potential multi-visceral resection.

引用

页数：3

共 11 条

[1] The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors [J].

Andersson, J ;

Sjögren, H ;

Meis-Kindblom, JM ;

Stenman, G ;

Åman, P ;

Kindblom, LG .

AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) :15-22

[2] Surgical resection of gastrointestinal stromal tumors after treatment with imatinib [J].

Andtbacka, Robert H. I. ;

Ng, Chaan S. ;

Scaife, Courtney L. ;

Cormier, Janice N. ;

Hunt, Kelly K. ;

Pisters, Peter W. T. ;

Pollock, Raphael E. ;

Benjamin, Robert S. ;

Burgess, Michael A. ;

Chen, Lei L. ;

Trent, Jonathan ;

Patel, Shreyaskumar R. ;

Raymond, Kevin ;

Feig, Barry W. .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :14-24

[3]

Dagher R, 2002, CLIN CANCER RES, V8, P3034

[4] Results of tyrosine-kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor [J].

DeMatteo, Ronald P. ;

Maki, Robert G. ;

Singer, Samuel ;

Gonen, Mithat ;

Brennan, Murray F. ;

Antonescu, Cristina R. .

ANNALS OF SURGERY, 2007, 245 (03) :347-352

[5] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[6]

GROCHI A, 2007, ANN SURG, V245, P341

[7] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J].

Joensuu, H ;

Roberts, PJ ;

Sarlomo-Rikala, M ;

Andersson, LC ;

Tervahartiala, P ;

Tuveson, D ;

Silberman, SL ;

Capdeville, R ;

Dimitrijevic, S ;

Druker, B ;

Demetri, GD .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1052-1056

[8]

Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728

[9] Drug therapy: Imatinib mesylate - A new oral targeted therapy. [J].

Savage, DG ;

Antman, KH .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :683-693

[10] Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study [J].

Van Glabbeke, M ;

Verweij, J ;

Casali, PG ;

Le Cesne, A ;

Hohenberger, P ;

Ray-Coquard, I ;

Schlemmer, M ;

van Oosterom, AT ;

Goldstein, D ;

Sciot, R ;

Hogendoorn, PCW ;

Brown, M ;

Bertulli, R ;

Judson, IR .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5795-5804

← 1 2 →